Evaluation of: Jensen LO, Thayssen P, Junker A et al. Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus and sirolimus-eluting stents (from the SORT OUT IV trial). Am. J. Cardiol. 110(11), 1585-1591 (2012). Percutaneous coronary interventions in diabetic patients are still challenging in the drug-eluting stents era because of the more extensive coronary artery disease and the presence of comorbidities. New-generation drug-eluting stents have demonstrated an improved efficacy and safety in patients treated with percutaneous coronary interventions. The SORT OUT IV substudy has investigated the clinical impact of the everolimus-eluting stents versus sirolimus-eluting stents in both the diabetic and nondiabetic population.
- diabetes mellitus
- drug-eluting stents
- major adverse cardiac events
- percutaneous coronary intervention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Internal Medicine